Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000811

Drug Information
SynonymsKBio2_001405; Orciprenalina [INN-Spanish]; Metaproterenol Polistirex (metaproterenol); CHEBI:144647; Spectrum2_000096; Spectrum3_000492; BSPBio_000429; Alotec; Astmopent; SAM002548965; Lopac0_000734; (RS)-1-(3,5-Dihydroxyphenyl)-2-isopropylaminoethanol; 586-06-1; KBioGR_000507; Orciprenalinum; 1,3-Benzenediol, 5-(1-hydroxy-2-((1-methylethyl)amino)ethyl)- (9CI); Spectrum5_000952; SPBio_000052; Benzyl alcohol, 3,5-dihydroxy-.alpha.-((isopropylamino)methyl)-; Orciprenalinum [INN-Latin]; HMS502A07; Orciprenaline (INN); Orciprenalina; BPBio1_000473; HMS1920L09; KBio3_001483; L000678; LS-42870; 3,5-Dihydroxy-alpha-((isopropylamino)methyl)benzyl alcohol; IDI1_000645; SPECTRUM1500390; Novasmasol; KBio2_006541; Prestwick3_000505; Orciprenaline [INN]; Benzyl alcohol, 3,5-dihydroxy-alpha-((isopropylamino)methyl)-; Prestwick0_000505; BRN 2807247; DB00816; Alupent; CHEMBL776; NCGC00015655-05; Spectrum4_000044; M-3070; 1,3-Benzenediol, 5-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]-; Metaprel; Metaproterenol polistirex; D08300; CPD001453712; CCRIS 9017; KBio2_003973; MolPort-003-666-227; Prestwick1_000505; NCGC00094718-01; NINDS_000645; EINECS 209-569-1; Prometa; KBio1_000645; Prestwick2_000505; SPBio_002350; KBioSS_001405; AC1L1HDP; Spectrum_000925; ORCIPRENALINE; CID4086; DivK1c_000645; NCGC00094718-02; 5-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,3-diol; BSPBio_001983; AB00052037; 1,3-Benzenediol, 5-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-; UNII-53QOG569E0; Orciprenaline sulfate; NCGC00094718-03; C07144; metaproterenol; Metaproterenol sulfate; HMS2091D04
Trade NameAlotec; Alupent; Metaprel; Novasmasol
[ICD9: 493   ICD10: J45]
Approved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Canonical SMILESCC(C)NCC(C1=CC(=CC(=C1)O)O)O    
Therapeutic ClassBronchodilator Agents
CAS NumberCAS 586-06-1
PubChem Compound IDCID 4086.
PubChem Substance IDSID 9353.
SuperDrug ATC IDR03AB03; R03CB03
SuperDrug CAS ID000586061;
TargetBeta-2 adrenergic receptorAgonist[2]
Ref 1Drug information of Orciprenaline, 2008 To Reference
Ref 2Male--female differences in the impact of beta-adrenoceptor stimulation on resistance to experimental metastasis: exploring the effects of age and gonadal hormone involvement. J Neuroimmunol. 2008 Jan;193(1-2):113-9. Epub 2007 Nov 26. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543